Aspek Klinis Rosasea
DOI:
https://doi.org/10.55175/cdk.v47i1.12Kata Kunci:
Eritema, rosasea, Erythema, rosaceaAbstrak
Rosasea merupakan penyakit inflamasi kulit kronik dengan tampilan eritema sentrofasial. Kelainan kulit ini memiliki berbagai faktor risiko seperti lingkungan, genetik, neurogenik, dan pengaruh infeksi mikroba, tetapi patogenesisnya belum dipahami sepenuhnya. Rosasea dapat menyerang siapapun terutama yang berusia > 31 tahun dan berkulit putih. Kelainan ini dapat mempengaruhi kualitas hidup seseorang. Klasifikasi subtipe rosasea dibagi menjadi 4 berdasarkan gejala klinis, yaitu erythematelangiectacic rosacea, papulopustular rosacea, phymatus rosacea, dan ocular rosacea. Perbedaan antar subtipe mempengaruhi terapi.
Rosacea is a common chronic skin condition with redness around the centrofacial area. This skin disease has many risk factors such as environment, genetic predisposition, neurogenic, and microbial, but its pathogenesis is still not fully understood. Rosacea can affect anybody, especially in the age group > 31 years old and fair skin. This skin condition can impair the quality of life. There are 4 subtype in rosacea classification based on clinical feature, eryhetmatelangiectacic rosacea, papulopustular rosacea, phymatus rosacea, and ocular rosacea. Different subtype needs different therapy.
Unduhan
Referensi
Sbidian E, Vicaut E, Chidiack H, Anselin E, Cribier B, Dreno B, et al. A randomized controlled trial of oral low dose isotretinoin for difficult to treat papulopustular rosacea. JID. 2016;136:1124-9.
Vella, Taufiq AV, Suyoso S. Klasifikasi baru dan patogenesis rosasea. BIKKK UNAIR. 2010;22(2):127-34.
Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick’s dermatology in general medicine. 8th ed. Vol 1. New York: McGraw-Hill; 2012.
Gether L, Overgaard LK, Egeberg A, Thyssen JP. Incidence and prevalence of rosacea: A systematic review and meta-analysis. BJD. 2018;179:282-9.
Indraprasta S, Setyaningrum T. Penelitian retrospektif: Profil penyakit rosasea. BIKKK UNAIR. 2015;27(2):114-20.
Mikkelsen CS, Holmgren HR, Kjellman P, Heidenheim M, Kappinnen A, Bjerring P, et al. Rosacea: A clinical review. Dermatol Rep. 2016;8:1-5.
Bolognia JL, Schaffer JV, Cerroni L, editors. Dermatology. 4thed. New Haven: Elsevier; 2018.
Weinkle AP, Doktor V, Emer J. Update on the management of rosacea. Clin Cosmetic Investig Dermatol J. 2015;8:159-77.
Griffiths C, Barker J, Bleiker T, Chalmers R, Creamer D. Rook’s textbook of dermatology. 4th ed. vol.3. Oxford: John Wiley & Sons; 2016.
Abokwidir M, Feldman SR. Rosacea management. Skin Appendage Disord. 2016;2:26-34.
Rivero AL, Whitfeld M. An update on the treatment of rosacea. Aust Prescr. 2018;41:20-4.
Schaller M, Almeida LMC, Bewley A, Cribier B, Dlova NC, Kautz G, et al. Rosacea treatment update: Recommendation from the global rosacea consensus panel. BJD. 2017;176:465-71.
Zuuren EJ, Fedorowicz Z. Low dose isotretinoin: An option for difficult to treat papulopustular rosacea. J Investig Dermatol. 2016;136:1081-3.
Lee WJ, Lee YJ, Lee MH, Won CH, Chang SE, Choi JH, et al. Prognosis of 234 rosacea patients according to clinical subtype: The significance of central facial erythema in the prognosis of rosacea. J Dermatol. 2016;43:526-31.
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2020 Cermin Dunia Kedokteran
Artikel ini berlisensi Creative Commons Attribution-NonCommercial 4.0 International License.
